Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
ClinicalTrials.gov study NCT01358071. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer
ClinicalTrials.gov study NCT06830850. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer
ClinicalTrials.gov study NCT02146313. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Kieser Resistance Training Plus Kieser Pelvic Floor Training vs. Kieser Resistance Training Plus Traditional Pelvic Floor Exercise on Urinary Incontinence in Prostate Cancer Patients After
ClinicalTrials.gov study NCT06206993. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II-b Randomized Clinical Trial of Cabazitaxel in Metastatic Colorectal Cancer Resistant to Standard Treatment
ClinicalTrials.gov study NCT02204332. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer
ClinicalTrials.gov study NCT06855069. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
ClinicalTrials.gov study NCT07035067. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT07240857. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of DMOT4039A in Participants With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT01469793. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance
ClinicalTrials.gov study NCT01714622. IPD Sharing: Not stated. Countries: 1. Publications: 0.
177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT04188587. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identifying Mechanisms of Resistance to mTOR Inhibitors in Cancer
ClinicalTrials.gov study NCT02306135. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparison of the Effectiveness of Supervised, Video-based and Home-based Resistance Exercise Program in Patients With Prostate Cancer
ClinicalTrials.gov study NCT06145243. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
ClinicalTrials.gov study NCT05601440. IPD Sharing: NO. Countries: 1. Publications: 0.
Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Tria
ClinicalTrials.gov study NCT06720532. IPD Sharing: NO. Countries: 1. Publications: 0.
Maveropepimut-S (MVP-S) and Low-Dose CPA in Patients With Platinum-Resistant Ovarian Cancer
ClinicalTrials.gov study NCT05243524. IPD Sharing: NO. Countries: 3. Publications: 0.
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT04585958. IPD Sharing: YES. Countries: 1. Publications: 0.
Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer
ClinicalTrials.gov study NCT06836726. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis
ClinicalTrials.gov study NCT00264082. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Newcastle Disease Virus (NDV) for Cancer Patients Resistant to Conventional Anti-cancer Modalities
ClinicalTrials.gov study NCT00348842. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.